Association Between Pharmacologic Treatment of Depression and Patient-Reported Outcomes Following Total Hip and Knee Arthroplasty.

Autor: Shadbolt C; Department of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Victoria, Australia., Schilling C; Department of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Victoria, Australia., Inacio MC; Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; University of South Australia, Allied Health and Human Performance, Adelaide, South Australia, Australia., Thuraisingam S; Department of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Victoria, Australia., Rele S; Department of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Victoria, Australia., Castle DJ; Department of Psychiatry, University of Tasmania, Sandy Bay, Tasmania, Australia; Department of Health, Centre for Mental Health Service Innovation, Tasmania, Australia., Choong PFM; Department of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Victoria, Australia; Department of Orthopaedics, St Vincent's Hospital Melbourne, Victoria, Australia., Dowsey MM; Department of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Victoria, Australia; Department of Orthopaedics, St Vincent's Hospital Melbourne, Victoria, Australia.
Jazyk: angličtina
Zdroj: The Journal of arthroplasty [J Arthroplasty] 2025 Jan; Vol. 40 (1), pp. 53-60.e4. Date of Electronic Publication: 2024 Jul 22.
DOI: 10.1016/j.arth.2024.07.023
Abstrakt: Background: Depression is associated with inferior outcomes following hip or knee arthroplasty, though it remains unclear if this relationship is modifiable. This study examined the association between pharmacologic treatment of depression and patient-reported outcomes.
Methods: This retrospective cohort study of 1,651 total hip arthroplasty (THA) and 1,792 total knee arthroplasty (TKA) procedures between October 2012 and June 2019 used institutional registry data linked to nationwide pharmaceutical claims. The primary outcome was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) global score, with pain and function subscales assessed as secondary outcomes. The TKA and THA patients were analyzed separately via mixed-effect linear regression to compare patients who had depression treated with antidepressants (TKA, n = 210; THA, n = 150) to those who had untreated depression (TKA, n = 43; THA; n = 50), and those who did not have depression (TKA, n = 1,539; THA, n = 1,451).
Results: Among patients who had depression, not receiving preoperative antidepressant therapy was associated with smaller improvements in WOMAC global scores (TKA, adjusted mean difference [MD]: -13.1 points, 95% CI [confidence interval]: -21.4 to -4.8; THA, MD: -8.5 points, 95% CI: -15.7 to -1.2) at 2 years after surgery, but not at 1 year (TKA, MD: -5.4 points, 95% CI: -12.9 to 2.1; THA, MD: -6.3 points, 95% CI: -12.9 to 0.3). Those who did not have depression had similar improvements in WOMAC global scores to those who had treated depression at both one (TKA, MD: 0.8 points, 95% CI: -2.7 to 4.4; THA, MD: 1.8 points, 95% CI: -1.8 to 5.4) and 2 years (TKA, MD: -1.1 points, 95% CI: -4.9 to 2.7; THA, MD: -1.6 points, 95% CI: -5.6 to 2.3). The findings were consistent with secondary outcomes.
Conclusions: Among patients who have depression, antidepressant therapy before TKA or THA is associated with improved outcomes. Additional studies are needed to establish the impact of interventions to address untreated depression before surgery.
(Copyright © 2024. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: